Advance your drug candidate seamlessly from preclinical to clinical phases with Nuvisan's scalable manufacturing capabilities. Our GMP-compliant facility is specifically designed for the production of small-scale APIs, supporting high quality for specialised applications such as orphan drugs, high-potency compounds, and ophthalmologic treatments.
Nuvisan delivers high-quality manufacturing solutions tailored to meet the needs of the pharmaceutical and biotech industries. With a focus on innovation, compliance and efficiency, our capabilities cover a broad range of requirements:
Nuvisan’s state-of-the-art facilities and dedicated teams ensure reliable and efficient manufacturing to accelerate your path to success.
Our comprehensive range of services, from process development to batch production, enables fast and efficient delivery of your drug substance. Both process development and kilogram-scale batch manufacturing are carried out at the same site by our highly skilled and flexible team of scientists. This integrated approach helps ensure timely delivery of pre-clinical supplies, while streamlining and reducing the costs of your clinical supplies.
We can produce batches ranging from 0.1 to 10 kg of intermediate or API in our kilo-lab, with rigorous impurity control to support pre-clinical studies. Our detailed batch records and technical package help facilitate a smooth transfer to a CMO for larger-scale API production.
In-process control (IPC) refers to monitoring and testing of parameters during the manufacturing process to help ensure the quality, consistency and safety of a drug substance.
At Nuvisan we offer:
By incorporating robust IPC, Nuvisan can enhance the efficiency, reliability and quality of your product, ensuring that the drug substance meets all necessary specifications throughout the production lifecycle.
Nuvisan offers services for the development and production of orphan drug batches, helping ensure that your rare disease treatments are delivered with the highest standards of quality and compliance.
Nuvisan's orphan drug manufacturing expertise helps you overcome rare disease treatment challenges, supporting your product's safety, efficacy, and availability.